Maybank IB says Genting's target price could be raised to RM8.86 if TauRX gains FDA approval for Alzheimer's drug – The Edge Markets MY
Maybank IB says Genting’s target price could be raised to RM8.86 if TauRX gains FDA approval for Alzheimer’s drug The Edge Markets MY
Source: Business News Feed